Gentaur Monalizumab – Anti-KLRC1 / NKG2A / CD159a Antibody
Recognizes inhibitory receptors on NK and CD8+ T-cells. Used to study immune evasion mechanisms in cancer and viral infection models.
Our latest content
Check out what's new in our company !
Your Dynamic Snippet will be displayed here... This message is displayed because you did not provide both a filter and a template to use.